Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma.
Balducci
Lodovico
L
Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. balducci@moffitt.usf.edu
Repetto
Lazzaro
L
D000368:Aged; D000375:Aging / Q000502:physiology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced* / Q000517:prevention & control*; D018579:Patient Selection
D003115:Colony-Stimulating Factors